Market Overview

UPDATE: Allscripts Posts 50% Decline In Q2 Profit, Lifts Full-Year Forecast

Related MDRX
Cookeville Medical Center Selects Allscripts for Chronic Care Management (CCM) Program
Allscripts Partners With CoverMyMeds to Help Patients Fill Prescriptions Faster
Allscripts' Sunrise Platform Selected By UHSM, Uptake High (Zacks)

Allscripts Healthcare Solutions (NASDAQ: MDRX) reported a 50% drop in its second-quarter profit.

For the full year, Allscripts lifted its earnings forecast. It now expects earnings of $0.77 to $0.83 per share, versus its earlier forecast of $0.74 to $0.80 per share.

Allscripts posted its quarterly profit at $8 million, or $0.04 per share, versus $15.9 million, or $0.08 per share, in the year-earluer period. Excluding other items, Allscripts earned $0.16 per share.

Its sales rose 3.7% to $370 million. However, analysts were estimating earnings of $0.18 per share on revenue of $370 million.

Its gross margin declined to 42.6% from 47%.

Allscripts shares closed at $9.60 yesterday.

Posted-In: profitEarnings News Guidance


Related Articles (MDRX)

View Comments and Join the Discussion!

Get Benzinga's Newsletters